Please complete the CAPTCHA to continue
@sbpdiscovery.org
✓
2 phones found area 407
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Layton Smith is listed as Senior Executive • Biomedical Research Scientist: Target-to-Clinic Drug Discovery • Pharmacology • Strategic Leadership ➢ I set and steer the research strategy to drive new and alternative therapies to patients worldwide at Zoe Biosciences, based in San Diego, California, United States. AeroLeads shows a work email signal at sbpdiscovery.org, phone signal with area code 407, and a matched LinkedIn profile for Layton Smith.
Layton Smith previously worked as Vice President, Drug Discovery at Zoe Biosciences and Senior Advisor | Principal | Founder at Calusa Chemical Biology Consultants, Llc. Layton Smith holds Ms, Clinical Investigation from Vanderbilt University School Of Medicine.
This section adds company-level context without repeating Layton Smith's masked contact details.
AeroLeads found 1 current-domain work email signal for Layton Smith. Compare company email patterns before reaching out.
With over 15 years of experience driving Target-to-Clinic drug discovery projects, I have built and led high-performance discovery teams, establishing the cross-functional collaboration necessary to advance discovery pipelines through IND. My journey has taken me from startups to major pharmaceutical players, where I've fostered a culture of trust, respect, and results.At Fate Therapeutics, I served as Vice President of Preclinical Pharmacology & Toxicology. In this role, I oversaw all in vivo studies essential for advancing Fate’s pipeline of iPSC-derived, genome-edited cellular therapies. A highlight was coordinating research efforts between Fate and Janssen Pharmaceutical, delivering two clinical development candidates. I managed both in-house and outsourced studies, delivering over 200 in vivo studies annually to support six concurrent discovery and late preclinical development programs.Before Fate, I was Executive Director and Head of Biology & Pharmacology at Sanford Burnham Prebys Medical Discovery Institute. There, I set the vision and drove the execution of biology and pharmacology operations, advancing high-risk, high-reward drug discovery projects. Leading a team of 25 with a multimillion-dollar budget, I expanded therapeutic area capabilities and secured $5 million in new funding to support over ten new research projects. Cultivating a relationship with an international chemical vendor, I established a new revenue stream and enhanced SBP's reputation for collaboration.My tenure at Sanford Burnham began as Director and Site Head of Drug Discovery, where I led over 30 FTEs in advancing a deep portfolio of drug discovery initiatives. Balancing resources between bi-coastal sites, I positioned operations toward long-term sustainability and instilled an “innovation first” mindset. This resulted in a first-in-class pipeline based on ownership, empowerment, and accountability. Securing a multiyear partnership with a global pharma company to innovate novel heart failure treatments was a key accomplishment.My academic background includes a Ph.D. in Pharmacology and an M.S. in Clinical Investigation from Vanderbilt University, as well as a B.S. in Cellular and Molecular Biology from Tulane University. Throughout my career, I have partnered with and fostered a culture of trust, respect, and results among team members at all levels, consistently driving drug discovery projects to successful outcomes and advancing the pharmaceutical industry.
Listed skills include Drug Discovery, Pharmacology, Assay Development, High Throughput Screening, and 17 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Joined founders of this start-up, pre-seed company focused on developing innovative therapies for age-related diseases and extending the human healthspan. I set the strategy to accelerate Zoe's pipeline of assets from late discovery into the clinic. I'm also supporting the CEO and CSO in their efforts to secure additional funding to take our lead asset.
As an independent consultant, I provide subject matter expertise (SME) in all aspects of early drug discovery, including assay development, HTS, ADME/DMPK, Target ID, Target assessment and derisking, molecular pharmacology, in vivo efficacy, and nonclinical development, IND.
San Diego, CA, US
Recruited by CSO and reporting to CEO, I spearheaded new initiatives in drug discovery at this seed stage, start-up company leveraging proprietary target stabilizing EMP technology. During this short contract task, my key contribution was to establish the first small molecule discovery program at Abilita. I designed and implemented a strategic plan to.
San Diego, California, US
I was recruited to oversee all in vivo studies essential for advancing Fate’s pipeline of iPSC-derived, genome-edited iNK and iT cellular therapies. I determined the preclinical scientific strategy to propel therapies for oncology and emerging new indications. Leading a large, multifunctional team, I provided daily results-oriented leadership, focusing on.
La Jolla, CA, US
I was promoted to set the vision and drive the execution of all aspects of biology and pharmacology operations at SBP, overseeing 25 FTEs and managing an annual budget of approximately $9M. My role was pivotal in propelling SBP's pipeline of high-risk, high-reward small-molecule and peptide drug discovery projects. As a subject matter expert in molecular.
La Jolla, CA, US
I was promoted to drive scientific excellence and bring a strategic development focus to a team of over 30 FTEs, advancing a deep portfolio of more than 50 drug discovery initiatives, ranging from concept to pre-clinical in vivo efficacy studies. I balanced resources between bi-coastal sites in collaboration with the Director of Medicinal Chemistry and the.
La Jolla, CA, US
I led groundbreaking research as an NIH-funded Principal Investigator, exploring the molecular pharmacology of the apelin system and its physiological and pathological roles, including its interaction with the renin-angiotensin system.I forged a strategic partnership with a global pharmaceutical company to develop novel heart failure treatments using small.
La Jolla, CA, US
I first joined the organization as an early member of the Pharmacology team. I established a new Pharmacology group and built out high-throughput ADME, DMPK and bioanalytical capabilities, expertly translating pharma Best Practices within the context of academic drug discovery
Quick answers generated from the profile data available on this page.
Layton Smith works for Zoe Biosciences.
Layton Smith is listed as Senior Executive • Biomedical Research Scientist: Target-to-Clinic Drug Discovery • Pharmacology • Strategic Leadership ➢ I set and steer the research strategy to drive new and alternative therapies to patients worldwide at Zoe Biosciences.
AeroLeads has found 1 work email signal at @sbpdiscovery.org for Layton Smith at Zoe Biosciences.
AeroLeads has found 2 phone signal(s) with area code 407 for Layton Smith at Zoe Biosciences.
Layton Smith is based in San Diego, California, United States while working with Zoe Biosciences.
Layton Smith has worked for Zoe Biosciences, Calusa Chemical Biology Consultants, Llc, Abilita Therapeutics, Inc., Fate Therapeutics Inc, and Sanford Burnham Prebys Medical Discovery Institute.
You can use AeroLeads to view verified contact signals for Layton Smith at Zoe Biosciences, including work email, phone, and LinkedIn data when available.
Layton Smith holds Ms, Clinical Investigation from Vanderbilt University School Of Medicine.
Layton Smith is listed with skills including Drug Discovery, Pharmacology, Assay Development, High Throughput Screening, Pharmacokinetics, In Vivo, Cross Functional Team Leadership, and Program Development.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts